Why Women May Be Less Likely to Receive Active Treatment for the Same Health Conditions

Women with the same health conditions as men may be less likely to be offered active treatment, according to recent reporting on sex-based differences in medical care. The issue has renewed attention on a long-standing question in healthcare: do women and men receive the same clinical options when their symptoms, diagnosis and medical needs are comparable?

A headline published by the University of St Andrews on 16 September 2026 reported that women were less likely than men to be offered active medical treatment for the same conditions. The finding was also covered by The Guardian and HuffPost UK. While the available reports do not establish that every woman receives different care, they highlight a potentially important inequality in clinical decision-making.

For patients, the message is not that treatment should be the same in every situation. Medical decisions must reflect factors such as age, pregnancy status, hormonal health, other conditions, medication use, risk level and personal preferences. However, when clinically relevant differences are accounted for, women should have equal access to appropriate investigations, specialist referrals and evidence-based treatment options.

What does “active treatment” mean?

The phrase “active treatment” can refer to an intervention intended to manage, control or improve a health condition rather than observation alone. Depending on the diagnosis, this may include prescription medication, a procedure, surgery, rehabilitation, specialist referral or structured follow-up.

It does not mean that every patient should automatically receive an invasive procedure or a particular drug. In some cases, monitoring is clinically appropriate. The concern raised by the recent coverage is whether women may be more likely to receive conservative management—or no treatment escalation—when a comparable male patient would be offered a more active option.

This distinction is important because treatment decisions are influenced not only by test results, but also by how symptoms are described, how seriously they are interpreted and how clinicians assess risk. If those judgments are affected by assumptions about sex or gender, patients may not receive equitable care.

Why might treatment decisions differ?

The reasons are likely to be complex. A difference in treatment rates does not, on its own, prove intentional discrimination or show that a particular clinician acted improperly. It may reflect several overlapping factors, including:

  • Differences in symptom presentation: The same disease may produce different or less typical symptoms in women. If clinical pathways are based mainly on male symptom patterns, diagnosis and treatment may be delayed.
  • Historical gaps in medical research: Women have not always been adequately represented in clinical research. As a result, some diagnostic tools and treatment guidelines may be based on evidence that does not fully reflect female patients.
  • Gender stereotypes: Symptoms such as pain, fatigue, breathlessness or dizziness may sometimes be attributed too quickly to stress, anxiety or emotional factors in women.
  • Communication barriers: Patients may describe symptoms differently, while clinicians may interpret the same words differently depending on the patient’s sex, age or background.
  • Risk assessment: Clinicians may make different assumptions about the likelihood of complications or the suitability of procedures, even when those assumptions are not supported by the individual’s clinical information.
  • System-level differences: Referral criteria, waiting lists, access to specialists and local treatment protocols can all influence whether a patient receives active care.

These factors can interact. A patient whose symptoms are initially minimised may be referred later, undergo fewer investigations and ultimately have fewer treatment choices. This can affect health outcomes, quality of life and confidence in the healthcare system.

Why the recent reports matter

The reports from September 2026 are significant because they focus on differences in treatment offers for the same conditions, rather than only on whether women are diagnosed later or experience different symptoms. That framing draws attention to what happens after a patient reaches the healthcare system.

Equal access does not necessarily mean identical care. A safe and appropriate treatment plan should be individualised. However, patients should be able to understand why a treatment is or is not being recommended, what alternatives exist and what may happen if they choose to wait.

Transparent explanations are particularly important where the evidence is uncertain or where several options may be reasonable. A patient should not have to rely on persistence, specialist knowledge or the ability to seek a second opinion simply to learn what treatments are available.

Conditions where sex differences may be overlooked

Sex-based differences in healthcare have been discussed across many areas of medicine, including cardiovascular disease, autoimmune disorders, chronic pain, neurological conditions and reproductive health. This does not mean that women and men always require the same tests or treatments. It means that clinical pathways should recognise how a condition may appear and progress in different patients.

For example, women may experience symptoms that do not match the most familiar textbook description of a disease. If clinicians rely too heavily on a “typical” presentation, a patient may receive reassurance rather than further evaluation. In other cases, women may be more likely to have symptoms labelled as non-specific, even when those symptoms are persistent or affecting daily life.

It is also important to consider intersectional factors. Age, ethnicity, disability, socioeconomic circumstances, language, body size and access to care may influence how symptoms are heard and how quickly treatment is offered. Sex-based inequality is therefore not experienced in exactly the same way by all women.

What can patients ask during a consultation?

Patients do not need to challenge their healthcare team aggressively to request clear information. Practical questions can help make the decision-making process more transparent:

  • What is the most likely explanation for my symptoms?
  • What tests or examinations are appropriate, and what will they show?
  • What treatment options are available, including non-surgical and non-medication approaches?
  • Why is this option recommended for me?
  • What are the potential benefits, risks and side effects?
  • What could happen if we monitor the condition instead?
  • When should I return or seek urgent medical attention?
  • Would a referral to a relevant specialist be appropriate?
  • Would a second opinion be useful?

Keeping a record of symptoms, previous test results, medication and important medical history can also support a more productive consultation. Patients may bring a trusted person to an appointment or ask for an interpreter when needed.

Seeking care internationally: what should patients consider?

International patients considering diagnosis or treatment abroad should focus on the quality and transparency of the clinical process, not only on the availability of a procedure. A reputable provider should request relevant medical records, review diagnostic information and explain whether treatment is genuinely indicated.

Before travelling to Türkiye or another country, patients should ask:

  • Who will assess the case, and what are their relevant qualifications?
  • Will the diagnosis be independently reviewed before treatment?
  • What alternatives to the proposed treatment are available?
  • What are the possible complications and follow-up requirements?
  • How will continuity of care be managed after returning home?
  • Are medical records, consent documents and treatment plans available in a language the patient understands?

Healthcare travel should never be based on a promise of guaranteed success or on pressure to accept immediate treatment. A second opinion can be valuable, but it should complement—not replace—appropriate local emergency care. Patients with severe or rapidly worsening symptoms should seek urgent medical attention in their current location.

A wider call for more equitable healthcare

The recent coverage adds to the broader discussion about sex and gender bias in medicine. Improving equity requires more than asking individual patients to advocate for themselves. Health systems can examine treatment patterns, improve research representation, strengthen clinician education and ensure that guidelines reflect diverse patient populations.

Clinicians can also support better care by listening carefully, documenting symptoms accurately and explaining how decisions are made. Researchers should continue investigating whether differences in diagnosis, referral and treatment remain after clinical factors are taken into account.

Conclusion

The September 2026 reports raise an important concern: women may not always be offered the same level of active treatment as men with comparable health conditions. The finding should not be interpreted as a reason for every patient to seek an intervention, but it does reinforce the importance of informed consent, individualised assessment and equal access to appropriate care.

Whether receiving care locally or considering treatment abroad, patients should be given a clear explanation of their diagnosis, options, risks and follow-up plan. If the reasoning behind a treatment decision is unclear, asking questions or seeking a qualified second opinion may help ensure that care is based on clinical evidence rather than assumptions.

Sources

This article is for general information only and does not replace an examination, diagnosis or treatment plan from a qualified healthcare professional.

Chat Support
×
Scroll to Top